e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel biomarkers and old parameters in clinical management of lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus
L. Fuso, C. Condoluci, E. Conte, D. Pitocco, C. Contu, A. Rizzi, B. Bibi, R. Antonelli Incalzi (Rome, Italy)
Source:
Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Session:
Novel biomarkers and old parameters in clinical management of lung diseases
Session type:
Poster Discussion
Number:
417
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Fuso, C. Condoluci, E. Conte, D. Pitocco, C. Contu, A. Rizzi, B. Bibi, R. Antonelli Incalzi (Rome, Italy). Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus. Eur Respir J 2013; 42: Suppl. 57, 417
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012
Lung function in children with juvenile diabetes type 1
Source: Eur Respir J 2002; 20: Suppl. 38, 139s
Year: 2002
Association between type 2 diabetes, prediabetes and lung function: Results from the KORA cohort
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
Respiratory muscle function in type 2 diabetes mellitus
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017
Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults
Source: Eur Respir J 2002; 20: 1406-1412
Year: 2002
Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Source: Eur Respir J 2008; 32: 962-969
Year: 2008
Pulmonary function tests in type 2 diabetes: a meta-analysis
Source: ERJ Open Res, 7 (1) 00371-2020; 10.1183/23120541.00371-2020
Year: 2021
Impact of
diabetes mellitus
on functional capacity and cardiac autonomic control: Spectral and non linear indices analysis
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013
Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003
Impaired exercise capacity in early stage liver cirrhosis - a prospective cross-sectional study
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Asthma and diabetes type 2 and their co-existence: Possible changes in lung function and their importance
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Changes in lung function in a rodent model of diabetes mellitus
Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function
Year: 2018
Diseases associated with restrictive lung function impairment
Source: Eur Respir Mon; 2009: 43: 142–149
Year: 2009
Metabolic regulation during the co-existence of COPD and DM type2
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Increased survival in lung cancer patients with diabetes mellitus: A large cohort study
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept